VISTA.AI has named Daniel Hawkins as its new President and CEO. The company specializes in AI-driven MRI image acquisition, aiming to enable MRI technicians to generate high-quality scans efficiently and affordably for various complex indications. Daniel’s appointment comes at a crucial juncture, following FDA clearance and successful early commercialization of their first product focused on Cardiac MRI (CMR). Going forward, the company intends to introduce AI-driven MRI capabilities for brain, spine, and other indications to complete its suite of offerings.
Daniel Hawkins, a seasoned entrepreneur and MedTech leader, has been appointed as President and CEO of VISTA.AI. With over three decades of experience in the industry, Daniel has held key roles in various established and early-stage companies, including Guidant (Abbott vascular), Intuitive Surgical, and Shockwave Medical. He is known for his contributions to market creation, product development, and driving successful go-to-market strategies.
Bruce Armstrong, Partner at Khosla Ventures, expressed confidence in Daniel’s leadership, highlighting VISTA.AI’s potential to revolutionize healthcare access and reduce costs. Daniel himself is enthusiastic about leading VISTA.AI’s innovative AI-based MRI technology, which aims to streamline MRI scans, particularly in specialties like cardiac, brain, and spine imaging.
VISTA.AI’s flagship product, One Click MRI™, is FDA cleared and focuses initially on cardiac MRIs (CMRs). The company plans to expand its AI-driven MRI capabilities to cover other anatomical areas, offering a comprehensive suite of solutions for clinicians and patients globally.
